Use of Radiomics in Mri Studies of Metastatic Liver Lesions

Currently, radiomics, as a rapidly developing technology, is increasingly used to solve diagnostic, prognostic and predictive problems in studies on liver metastases based on MRI images. In addition to its effectiveness in diagnosing and classifying tumors, radiomics demonstrates particularly impressive prognostic capabilities for malignant liver tumors (MLT) of the liver as a high-risk organ. Before the advent of radiomics, molecular genetic, biochemical and histological studies were used for these purposes. Radiomics of liver MLT is in its early stages of development, which suggests the presence of certain difficulties and obstacles, the elimination of which is the primary focus, in particular, in the field of developing standards necessary for use in clinical practice.